Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

NASDAQ:RUN - Nasdaq - US86771W1053 - Common Stock - Currency: USD

11.85  -0.15 (-1.25%)

After market: 11.8975 +0.05 (+0.4%)

Fundamental Rating

2

RUN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 93 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RUN was profitable.
In the past year RUN has reported a negative cash flow from operations.
RUN had negative earnings in 4 of the past 5 years.
In the past 5 years RUN always reported negative operating cash flow.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

RUN's Return On Assets of -13.29% is in line compared to the rest of the industry. RUN outperforms 55.91% of its industry peers.
Looking at the Return On Equity, with a value of -103.55%, RUN is doing worse than 61.29% of the companies in the same industry.
Industry RankSector Rank
ROA -13.29%
ROE -103.55%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

With a Gross Margin value of 18.95%, RUN perfoms like the industry average, outperforming 44.09% of the companies in the same industry.
In the last couple of years the Gross Margin of RUN has declined.
The Profit Margin and Operating Margin are not available for RUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RUN has more shares outstanding
Compared to 5 years ago, RUN has more shares outstanding
Compared to 1 year ago, RUN has a worse debt to assets ratio.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.15, we must say that RUN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.15, RUN perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
RUN has a Debt/Equity ratio of 5.11. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RUN (5.11) is worse than 79.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.11
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACCN/A
WACC4.86%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.32 indicates that RUN should not have too much problems paying its short term obligations.
The Current ratio of RUN (1.32) is worse than 62.37% of its industry peers.
A Quick Ratio of 0.99 indicates that RUN may have some problems paying its short term obligations.
With a Quick ratio value of 0.99, RUN perfoms like the industry average, outperforming 47.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.99
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 136.26% over the past year.
Measured over the past years, RUN shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.86% on average per year.
Looking at the last year, RUN shows a decrease in Revenue. The Revenue has decreased by -9.83% in the last year.
Measured over the past years, RUN shows a quite strong growth in Revenue. The Revenue has been growing by 18.87% on average per year.
EPS 1Y (TTM)136.26%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%94.55%
Revenue 1Y (TTM)-9.83%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%8.68%

3.2 Future

The Earnings Per Share is expected to grow by 35.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, RUN will show a quite strong growth in Revenue. The Revenue will grow by 9.27% on average per year.
EPS Next Y-147.71%
EPS Next 2Y-64.08%
EPS Next 3Y-39.98%
EPS Next 5Y35.19%
Revenue Next Year9.23%
Revenue Next 2Y10.01%
Revenue Next 3Y11.65%
Revenue Next 5Y9.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.13, which indicates a rather cheap valuation of RUN.
RUN's Price/Earnings ratio is rather cheap when compared to the industry. RUN is cheaper than 96.77% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, RUN is valued rather cheaply.
RUN is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 5.13
Fwd PE N/A
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RUN indicates a somewhat cheap valuation: RUN is cheaper than 62.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 116.26
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

RUN's earnings are expected to decrease with -39.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-64.08%
EPS Next 3Y-39.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (8/8/2025, 8:05:22 PM)

After market: 11.8975 +0.05 (+0.4%)

11.85

-0.15 (-1.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners119.83%
Inst Owner Change2.97%
Ins Owners9.15%
Ins Owner Change3.84%
Market Cap2.71B
Analysts69.29
Price Target12.46 (5.15%)
Short Float %27.91%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)407.56%
Min EPS beat(2)168.55%
Max EPS beat(2)646.57%
EPS beat(4)3
Avg EPS beat(4)231.07%
Min EPS beat(4)-157.51%
Max EPS beat(4)646.57%
EPS beat(8)5
Avg EPS beat(8)-194.18%
EPS beat(12)8
Avg EPS beat(12)-76.31%
EPS beat(16)9
Avg EPS beat(16)-55.76%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-4.56%
Max Revenue beat(2)3.14%
Revenue beat(4)2
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)3.14%
Revenue beat(8)2
Avg Revenue beat(8)-3.07%
Revenue beat(12)6
Avg Revenue beat(12)1.46%
Revenue beat(16)10
Avg Revenue beat(16)3.65%
PT rev (1m)9.69%
PT rev (3m)-0.05%
EPS NQ rev (1m)6.79%
EPS NQ rev (3m)-8.37%
EPS NY rev (1m)0%
EPS NY rev (3m)58.17%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)1.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 5.13
Fwd PE N/A
P/S 1.3
P/FCF N/A
P/OCF N/A
P/B 1.04
P/tB 1.04
EV/EBITDA 116.26
EPS(TTM)2.31
EY19.49%
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-15.51
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS9.12
BVpS11.45
TBVpS11.45
PEG (NY)N/A
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA -13.29%
ROE -103.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.95%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 5.11
Debt/FCF N/A
Debt/EBITDA 98.7
Cap/Depr 440%
Cap/Sales 135.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.99
Altman-Z -0.15
F-Score4
WACC4.86%
ROIC/WACCN/A
Cap/Depr(3y)457.15%
Cap/Depr(5y)441.02%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)136.26%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%94.55%
EPS Next Y-147.71%
EPS Next 2Y-64.08%
EPS Next 3Y-39.98%
EPS Next 5Y35.19%
Revenue 1Y (TTM)-9.83%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%8.68%
Revenue Next Year9.23%
Revenue Next 2Y10.01%
Revenue Next 3Y11.65%
Revenue Next 5Y9.27%
EBIT growth 1Y34.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.88%
EBIT Next 3Y42.76%
EBIT Next 5Y30.2%
FCF growth 1Y-13.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.51%
OCF growth 3YN/A
OCF growth 5YN/A